Kirsten Gruis
2022
In 2022, Kirsten Gruis earned a total compensation of $1M as Chief Medical Officer at DiaMedica Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $137,085 |
|---|---|
| Option Awards | $487,789 |
| Salary | $364,167 |
| Other | $15,650 |
| Total | $1,004,691 |
Gruis received $487.8K in option awards, accounting for 49% of the total pay in 2022.
Gruis also received $137.1K in non-equity incentive plan, $364.2K in salary and $15.7K in other compensation.
Rankings
In 2022, Kirsten Gruis' compensation ranked 3,020th out of 5,758 executives tracked by ExecPay. In other words, Gruis earned more than 47.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,020 out of 5,758 | 48th |
Division Manufacturing | 1,695 out of 3,135 | 46th |
Major group Chemicals And Allied Products | 796 out of 1,421 | 44th |
Industry group Drugs | 743 out of 1,322 | 44th |
Industry Pharmaceutical Preparations | 539 out of 968 | 44th |
Source: SEC filing on April 4, 2023.
Gruis' colleagues
We found two more compensation records of executives who worked with Kirsten Gruis at DiaMedica Therapeutics in 2022.